scholarly article | Q13442814 |
P356 | DOI | 10.1200/JCO.2010.30.6985 |
P953 | full work available online at | http://intl.jco.org/cgi/content/abstract/29/10/1290 |
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.30.6985 | ||
https://doi.org/10.1200/jco.2010.30.6985 | ||
https://europepmc.org/articles/PMC3083997 | ||
https://europepmc.org/articles/pmc3083997?pdf=render | ||
https://europepmc.org/articles/PMC3083997?pdf=render | ||
P932 | PMC publication ID | 3083997 |
P698 | PubMed publication ID | 21357782 |
P5875 | ResearchGate publication ID | 50226884 |
P50 | author | Arti Hurria | Q88804859 |
William P Tew | Q91946609 | ||
Kayo Togawa | Q102071711 | ||
Hyman B Muss | Q104758257 | ||
Andrew S Artz | Q114373337 | ||
Alice B Kornblith | Q114373341 | ||
Harvey Jay Cohen | Q114373342 | ||
Constance T Cirrincione | Q114373346 | ||
Vani Katheria | Q114373348 | ||
Jeffrey A Kirshner | Q117235231 | ||
P2093 | author name string | Ilene Galinsky | |
Richard Stone | |||
William Barry | |||
Rafat Ansari | |||
John Postiglione | |||
Douglas Weckstein | |||
Jeffrey Kirshner | |||
Kurt Hansen | |||
Linda Schmieder | |||
P2860 | cites work | The hospital anxiety and depression scale | Q27860968 |
The timed "Up & Go": a test of basic functional mobility for frail elderly persons | Q29615553 | ||
Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. | Q33228030 | ||
Distress in older patients with cancer | Q33561136 | ||
Aging and cancer in America. Demographic and epidemiologic perspectives | Q33841117 | ||
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group | Q34057488 | ||
Adjuvant chemotherapy in older and younger women with lymph node-positive breast cancer | Q36059237 | ||
Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). | Q36220834 | ||
Comprehensive geriatric assessment for older patients with cancer | Q36815525 | ||
Development of a cancer-specific Comprehensive Geriatric Assessment in a University Hospital in Spain | Q37721571 | ||
The MOS social support survey | Q39513264 | ||
Mentoring junior faculty in geriatric oncology: report from the Cancer and Aging Research Group | Q39744643 | ||
Relation between cognitive impairment and early death in the elderly | Q39897841 | ||
Future of cancer incidence in the United States: burdens upon an aging, changing nation | Q39983611 | ||
Predictors of immediate and 6-month outcomes in hospitalized elderly patients. The importance of functional status. | Q41268153 | ||
A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients | Q43763447 | ||
Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology | Q43872786 | ||
A reevaluation of the duration of survival after the onset of dementia. | Q44769730 | ||
Prospective evaluation of the pharmacokinetics and toxicity profile of docetaxel in the elderly. | Q45271704 | ||
A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. | Q45948421 | ||
Value of functional status as a predictor of mortality: results of a prospective study | Q46584814 | ||
The effect of comorbidity on 3-year survival of women with primary breast cancer | Q46637774 | ||
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the eld | Q46726889 | ||
Enrolling older persons in cancer trials: the effect of sociodemographic, protocol, and recruitment center characteristics | Q46867577 | ||
Weight change in old age and its association with mortality | Q47190927 | ||
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials | Q50120629 | ||
Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study | Q51927016 | ||
Geriatric evaluation and management units in the care of the frail elderly cancer patient | Q51928600 | ||
Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. | Q51960759 | ||
Functional impairment in instrumental activities of daily living: an early clinical sign of dementia? | Q51985670 | ||
Reliability of the Blessed Telephone Information-Memory-Concentration Test | Q52051401 | ||
The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire | Q52101368 | ||
Validation of a short Orientation-Memory-Concentration Test of cognitive impairment | Q52215816 | ||
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. | Q53337715 | ||
Body mass index and mortality among older people living in the community | Q53792771 | ||
Toxicity of Older and Younger Patients Treated With Adjuvant Chemotherapy for Node-Positive Breast Cancer: The Cancer and Leukemia Group B Experience | Q57578427 | ||
Social support as a buffer to the psychological impact of stressful life events in women with breast cancer | Q57578626 | ||
Validation of a multidimensional evaluation scale for use in elderly cancer patients | Q59504113 | ||
Developing a cancer-specific geriatric assessment | Q59566082 | ||
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group | Q72274218 | ||
Intercommunity variations in the association between social ties and mortality in the elderly. A comparative analysis of three communities | Q72691540 | ||
Underrepresentation of patients 65 years of age or older in cancer-treatment trials | Q73311140 | ||
Body mass index and mortality among hospitalized patients | Q74352991 | ||
Participation in cancer clinical trials: race-, sex-, and age-based disparities | Q80179103 | ||
Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration | Q81002008 | ||
Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001 | Q81596065 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cognition | Q2200417 |
aged care assessment | Q65716033 | ||
P304 | page(s) | 1290-1296 | |
P577 | publication date | 2011-02-28 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401 | |
Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401 | |||
P478 | volume | 29 |
Q37602881 | A Gap in Disease-Specific Survival Between Younger and Older Adults With De Novo Metastatic Renal Cell Carcinoma: Results of a SEER Database Analysis |
Q38822165 | A comprehensive geriatric assessment screening questionnaire (CGA-GOLD) for older people undergoing treatment for cancer. |
Q40970006 | A retrospective comparison of older and younger adults undergoing early laparoscopic cholecystectomy for mild to moderate calculous cholecystitis |
Q26822701 | Adjuvant Chemotherapy in Older Adults with Non–Small Cell Lung Cancer |
Q84292265 | Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An Underused Lifesaving Treatment |
Q37884483 | Adjuvant chemotherapy for breast cancer in older women: emerging evidence to aid in decision making |
Q28066744 | Adjuvant treatment for older women with invasive breast cancer |
Q38997213 | Age-related Disparity: Breast Cancer in the Elderly |
Q39013605 | Aging: Treating the Older Patient |
Q35047679 | An update on a systematic review of the use of geriatric assessment for older adults in oncology |
Q98948704 | Association of malnutrition with geriatric assessment impairments and health-related quality of life among older adults with gastrointestinal malignancies |
Q84310974 | Basic Assessment of the Older Cancer Patient |
Q30240259 | Biologic vs physiologic age in the transplant candidate. |
Q35894352 | Biological, clinical, and psychosocial correlates at the interface of cancer and aging research |
Q39303318 | Breast cancer in the elderly: which lessons have we learned? |
Q87938502 | Breast cancer-specific survival by age: Worse outcomes for the oldest patients |
Q47945603 | Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance). |
Q39019794 | Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study |
Q35567604 | Chemotherapy for colorectal cancer in the elderly |
Q26771424 | Chemotherapy in Elderly Patients with Gastric Cancer |
Q83425168 | Comprehensive Geriatric Assessment and Its Clinical Impact in Oncology |
Q35021464 | Comprehensive geriatric assessment in the older cancer patient: coming of age in clinical cancer care |
Q26851579 | Concurrent systemic therapy with radiotherapy for the treatment of poor-risk patients with unresectable stage III non-small-cell lung cancer: a review of the literature |
Q47570706 | Considerations for clinical trial design in older adults with cancer |
Q38232184 | Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC). |
Q30244769 | Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer |
Q38967020 | Definition of Unfit for Standard Acute Myeloid Leukemia Therapy |
Q34155010 | Determining chemotherapy tolerance in older patients with cancer |
Q90181661 | Developing a clinical and biological measures of aging core: Cancer and Aging Research Group infrastructure |
Q92658251 | Effects of cancer history on functional age and mortality |
Q38458166 | Elderly acute myeloid leukemia: assessing risk |
Q85077956 | Embracing the Complexity of Comorbidity |
Q90752405 | Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper |
Q33816617 | Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012 |
Q37698199 | Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer |
Q44898238 | Expert insights into the contemporary management of older adults with acute myeloid leukemia |
Q57146025 | Factors associated with falls in older adults with cancer: a validated model from the Cancer and Aging Research Group |
Q40735826 | Falls in Older Adults With Cancer: Evaluation by Oncology Providers. |
Q36565645 | Feasibility of Computer-Based Self-Administered Cancer-Specific Geriatric Assessment in Older Patients With Gastrointestinal Malignancy |
Q30240298 | Fitness in the elderly: how to make decisions regarding acute myeloid leukemia induction. |
Q39450412 | Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology. |
Q33563551 | Frailty and inflammatory markers in older adults with cancer |
Q88856352 | Frailty and skeletal muscle in older adults with cancer |
Q46725601 | Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy |
Q90066436 | Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age |
Q55360943 | Frailty in Hematologic Malignancy. |
Q60685780 | Geriatric Assessment in Older Patients with Acute Myeloid Leukemia |
Q36242685 | Geriatric Assessment-Guided Care Processes for Older Adults: A Delphi Consensus of Geriatric Oncology Experts. |
Q35793214 | Geriatric assessment as an aide to understanding falls in older adults with cancer. |
Q34713833 | Geriatric assessment in surgical oncology: a systematic review |
Q36940190 | Geriatric assessment is associated with completion of chemotherapy, toxicity, and survival in older adults with cancer |
Q33978945 | Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. |
Q35345579 | Geriatric assessment-identified deficits in older cancer patients with normal performance status |
Q37082755 | Geriatric oncology research to improve clinical care |
Q92500556 | Hematopoietic Cell Transplant-Related Toxicities and Mortality in Frail Recipients |
Q39419031 | How I treat older patients with ALL |
Q34359304 | How to implement a geriatric assessment in your clinical practice |
Q36807321 | Impact of age on treatment trends and clinical outcome in patients with metastatic renal cell carcinoma |
Q38013985 | Integrating a Cancer-Specific Geriatric Assessment Into Survivorship Care |
Q38044116 | Integrating a Geriatric Evaluation in the Clinical Setting |
Q90040966 | Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE) |
Q38489690 | Integrating oncogeriatric tools into the management of chronic lymphocytic leukemia: current state of the art and challenges for the future. |
Q36925135 | International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer |
Q39001325 | Management of Elderly Patients with Plasma Cell Myeloma |
Q37999119 | Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). |
Q37531318 | Managing breast cancer in the older patient |
Q90256785 | Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects |
Q92675662 | Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy |
Q38749994 | Navigating the Challenges of Adjuvant Chemotherapy in Older Patients with Early-Stage Non-Small-Cell Lung Cancer |
Q44240468 | Older Women With Breast Cancer: Slow Progress, Great Opportunity, Now Is the Time |
Q98906822 | Older adults with cancer and their caregivers - current landscape and future directions for clinical care |
Q38058455 | Optimal Management of Recurrent Prostate Cancer in Older Patients |
Q34514273 | Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates |
Q50634666 | Patient-centered, evidence-based, and cost-conscious cancer care across the continuum: Translating the Institute of Medicine report into clinical practice |
Q38676390 | Patterns of Care and Survival for Elderly Acute Myeloid Leukemia-Challenges and Opportunities |
Q36406979 | Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older. |
Q88755207 | Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology |
Q56334854 | Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study |
Q48053063 | Predicting fatigue in older breast cancer patients receiving radiotherapy. A head-to-head comparison of established assessments |
Q35514012 | Predicting participation in meaningful activity for older adults with cancer. |
Q35771257 | Predictors of chemotherapy dose reduction at first cycle in patients age 65 years and older with solid tumors |
Q104693491 | Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative |
Q52576597 | Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602). |
Q37626917 | Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program. |
Q39394041 | Reliability, Validity, and Feasibility of a Computer-Based Geriatric Assessment for Older Adults With Cancer |
Q37105824 | Research Priorities in Geriatric Oncology: Addressing the Needs of an Aging Population |
Q34386081 | Research priorities in geriatric oncology for 2013 and beyond. |
Q37242523 | Safety and Effectiveness of Oxaliplatin-Based Chemotherapy Regimens in Adults 75 Years and Older With Colorectal Cancer |
Q36851424 | Senior adult oncology |
Q28079170 | Specific Aspects of Breast Cancer Therapy of Elderly Women |
Q36774769 | Sublobar resection versus lobectomy in Surgical Treatment of Elderly Patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial |
Q35989968 | Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGA. |
Q26785458 | Taxanes in the elderly patient with metastatic breast cancer |
Q36556444 | The Evolution of Gero-Oncology Nursing |
Q34968015 | The SAKK cancer-specific geriatric assessment (C-SGA): a pilot study of a brieftool for clinical decision-making in older cancer patients |
Q33921226 | The effect of aromatase inhibition on the cognitive function of older patients with breast cancer. |
Q38102826 | Treating octogenarians with muscle-invasive bladder cancer: Preoperative opportunities for increasing the benefits of surgical intervention |
Q37876082 | Treatment of Advanced Lung Cancer in the Elderly |
Q38594154 | Treatment of Breast Cancer in the Elderly |
Q47774455 | Treatment of Older Patients with Acute Lymphoblastic Leukaemia |
Q26744163 | Treatment of bladder cancer in the elderly |
Q37965641 | Treatment of elderly patients with stage IV non-small-cell lung cancer |
Q38023511 | Treatment of metastatic breast cancer in women aged 65 years and older |
Q38615547 | Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit |
Q38275362 | Treatment of ovarian cancer in the older woman |
Q53199885 | Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoo |
Q58049269 | Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant |
Q34360763 | Use of geriatric assessment for older adults in the oncology setting: a systematic review. |
Q52364992 | Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients. |
Q37659124 | Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer. |
Q50045189 | What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper. |
Q89798054 | When It Comes to Geriatric Assessment, Rome Was Not Built in One Day |
Search more.